A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma

计划入组 95 人 · 首次发布于 2017 年 9 月 26 日

A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (HCC)

计划入组 14 人 · 首次发布于 2017 年 3 月 6 日

A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in Refractory Colorectal Cancer

计划入组 34 人 · 首次发布于 2017 年 7 月 2 日

Pexastimogene devacirepvec

Pexa-Vec/ Icaritin combination(Lee's Pharmaceutical/ Beijing Shenogen Pharma)

Pexacerfont

C₁₈H₂₄N₆O

Opexa Therapeutics, Inc.

United States

GLORIOUS DEXA SINGAPORE PTE. LTD.

Singapore

ASSOCIACAO DOS EX-ALUNOS POS-GRADUADOS EM ORTODONTIA PELA FACULDADE DE ODONTOLOGIA DA UNIVERSIDADE DE SAO PAULOFOUSP

Brazil

PExA Signs 7.5 MSEK Contract with Top-10 Global Pharma for IPF Clinical Study Using PEXA 2.1 Systems

Fraunhofer Researchers Develop Breakthrough Method to Measure Lung Drug Levels Through Exhaled Breath Particles

DEXA-PSYCH Trial Investigates Dexamethasone as Rapid-Acting Depression Treatment